Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-489z4 Total loading time: 0.629 Render date: 2022-05-23T20:38:29.604Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Book contents

11 - Management of cancer of the head and neck

Published online by Cambridge University Press:  05 November 2015

Nachi Palaniappan
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff, UK
Waheeda Owadally
Affiliation:
University Hospitals Bristol, Bristol, UK
Mererid Evans
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff, UK
Louise Hanna
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adelstein, D. J., Koyfman, S. A., El-Naggar, A.K., et al. (2012). Biology and management of salivary gland cancers. Semin. Radiat. Oncol. 22, 245–253.CrossRefGoogle ScholarPubMed
AJCC. (2009). AJCC Cancer Staging Manual, ed. Edge, S. B., Byrd, D. R., Compton, C. C., et al., 7th edn. Chicago: American Joint Committee on Cancer.
Al-Sarraf, M., LeBlanc, M., Giri, P. G., et al. (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomised intergroup study 0099. J. Clin. Oncol. 16, 1310–1317.CrossRefGoogle Scholar
Ang, K. K., Trotti, A., Brown, B. W., et al. (2001). Randomised trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 51, 571–578.CrossRefGoogle Scholar
Ang, K. K., Harris, J., Wheeler, R., et al. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24–35.CrossRefGoogle ScholarPubMed
Ang, K. K., Zhang, Q., Rosenthal, D. I., et al. (2014). Randomised phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III or IV head and neck carcinoma: RTOG 0522. J. Clin. Oncol., JCO.2013.53.5633, published online on 25 August 2014.CrossRefGoogle ScholarPubMed
Argiris, A., Li, Y., Forastiere, A., et al. (2004). Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of head and neck. Cancer 101, 2222–2229.CrossRefGoogle ScholarPubMed
Armstrong, J. G., Harrison, L. B., Thaler, H. T., et al. (1992). The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69, 615–619.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Baujat, B., Audry, H., Bourhis, J., et al. (2006). Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst. Rev. Issue 4 Art No. CD004329.Google Scholar
Bernier, J., Domenge, C., Ozsahin, M., et al. (2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 350, 1945–1952.CrossRefGoogle ScholarPubMed
Blanchard, P., Bourhis, J., Lacas, B., et al. (2013). Taxane–cisplatin–fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis. J. Clin. Oncol. 31, 2854–2860.CrossRefGoogle ScholarPubMed
Bonner, J. A., Harari, P. M., Giralt, J., et al. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354, 567–578.CrossRefGoogle ScholarPubMed
Bourhis, J., Overgaard, J., Audry, H., et al. (2006). Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet, 368, 843–854.CrossRefGoogle ScholarPubMed
British Association of Otorhinolaryngology. (2011). Head and Neck Cancers: Multidisciplinary Management Guidelines, 4th edn. London: ENT UK.
Cancer Research UK. (2010). UK Cancer Incidence (2010) by Country Summary, April 2013. http://publications.cancerresearchuk.org/downloads/Product/CS_DT_INCCOUNTRIES.pdf (accessed December 2014).
Cooper, J. S., Pajak, T. F., Forastiere, A. A., et al. (2004). Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N. Engl. J. Med. 350, 1937–1944.CrossRefGoogle ScholarPubMed
Dulguerov, P., Jacobsen, M. S., Allal, A. S., et al. (2001). Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92, 3012–3029.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Forastiere, A. A., Metch, B., Schuller, D. E., et al. (1992). Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J. Clin. Onco., 10, 1245–1251.CrossRefGoogle ScholarPubMed
Forastiere, A. A., Goepfert, H., Maor, M., et al. (2003). Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 349, 2091–2098.CrossRefGoogle ScholarPubMed
Frank, S. J., Rosenthal, D. I., Petsuksiri, J., et al. (2010). Intensity modulated radiotherapy for cervical node squamous cell carcinoma metastasis from unknown head and neck primary site: M.D. Anderson Cancer Centre outcomes and patterns of failure. Int. J. Radiat. Oncol. Biol. Phys. 78, 1005–1010.CrossRefGoogle Scholar
Ghi, M. G., Paccagnella, A., Ferrari, D., et al. (2014). Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction docetaxel/cisplatin/5-fluorouracil followed by CRT or CET/RT in patients with locally advanced squamous cell carcinoma of head and neck – A randomised phase III factorial study. J. Clin. Oncol. 32, 5s, suppl; abstr. 6004.Google Scholar
Gibson, M. K., Li, Y., Murphy, B., et al. (2005). Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 23, 3562–3567.CrossRefGoogle ScholarPubMed
Grégoire, V., Ang, K. K., Budach, W., et al. (2014). Delineation of the neck node levels for head and neck tumours: A 2013 update, Consensus guidelines. Radiother. Oncol. 110, 172–181.CrossRefGoogle ScholarPubMed
Jegoux, F., Metreau, A., Louvel, G., et al. (2013). Paranasal sinus cancer. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 130, 327–335.CrossRefGoogle ScholarPubMed
Langendijk, J. A., Leemans, C. R., Buter, J., et al. (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature. J. Clin. Oncol. 22, 4604–4612.CrossRefGoogle ScholarPubMed
Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, I. M., et al. (2008). Impact of late treatment related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.J. Clin. Oncol. 26, 3770–3776.CrossRefGoogle ScholarPubMed
Lavaf, A., Genden, E. M., Cesaretti, J. A., et al. (2008). Adjuvant radiotherapy improves overall survival for patients with lymph node positive head and neck squamous cell carcinoma. Cancer 112, 535–543.CrossRefGoogle ScholarPubMed
Lee, N., Harris, J., Garden, A. S., et al. (2009). Intensity-Modulated Radiation Therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225. J. Clin. Oncol. 22, 3684–3690.Google Scholar
Lee, A., Lin, J. C. and Ng, W. T. (2012). Current management of nasopharyngeal cancer. Semin. Radiat. Oncol. 22, 233–244.CrossRefGoogle ScholarPubMed
Machtay, M., Moughan, J., Trotti, A., et al. (2008). Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer; An RTOG Analysis. J. Clin. Oncol. 26, 3582–3589.CrossRefGoogle ScholarPubMed
Mehanna, H., Rattay, T., Smith, J., et al. (2009). Treatment and follow up of oral dysplasia – a systematic review and meta-analysis. Head Neck 31, 1600–1609.CrossRefGoogle ScholarPubMed
Mehanna, H., Beech, T., Nicholson, T., et al. (2013). Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer – Systematic review and meta-analysis of trends by time and region. Head Neck 35, 747–755.CrossRefGoogle ScholarPubMed
Mehanna, H. M., Wong, W. L., McConkey, C. C., et al. (2015). PET-NECK: a multi-centre, radomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT).J. Clin. Oncol., 33, 2015 (suppl; abstr 6009).
Mishra, R. C., Singh, D.N., Mishra, T. K., et al. (1996). Post-operative radiotherapy in carcinoma buccal mucosa, a prospective randomised trial. Eur. J. Surg. Oncol. 22, 502–504.CrossRefGoogle Scholar
Moore, E. J. and Hinni, M. L. (2013). Critical review: Transoral laser microsurgery and robotic assisted surgery for oropharynx cancer including human papillomavirus-related cancer. Int. J. Radiat. Oncol. Biol. Phys. 85, 1163–1167.CrossRefGoogle ScholarPubMed
National Cancer Intelligence Network. (2010). Profile of Head and Neck Cancers in England – Incidence, Mortality and Survival.Oxford: Oxford Cancer Intelligence Unit.
Nutting, C. M., Morden, J. P., Harrington, K. J., et al. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol. 12, 127–136.CrossRefGoogle ScholarPubMed
Overgaard, J., Hansen, H., Specht, L., et al. (2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362, 933–940.CrossRefGoogle ScholarPubMed
Parsons, J. T., Medenhall, W. M., Stringer, S. P., et al. (2002). Squamous cell carcinoma of the oropharynx: surgery, radiation therapy or both. Cancer 94, 2967–2980.CrossRefGoogle ScholarPubMed
Pignon, J. P., le Maître, A., Maillard, E., et al. (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 92, 4–14.CrossRefGoogle ScholarPubMed
Pointreau, Y., Garaud, P., Chapet, S., et al. (2009). Randomised trial of induction chemotherapy with cisplatin and 5FU with or without docetaxel for larynx preservation. J. Natl. Cancer Inst. 101, 498–506.Google ScholarPubMed
Pow, E. H., Kwong, D. L., McMillan, A. S., et al. (2006). Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial results on a randomised controlled trial. Int. J. Radiat. Oncol. Biol. Phys. 66, 981–991.CrossRefGoogle Scholar
Shanmugaratnam, K., Sobin, L. H. and World Health Organization. (1978). Histological Typing of Upper Respiratory Tract Tumours. International Histological Classification of Tumours: no. 19.Geneva: World Health Organization.Google Scholar
Sher, D. J., Balboni, T. A., Haddad, R. I., et al. (2011). Efficacy and toxicity of chemoradiotherapy using intensity modulated radiotherapy for unknown primary of head and neck. Int. J. Radiat. Oncol. Biol. Phys. 80, 1405–1411.CrossRefGoogle ScholarPubMed
Takes, R. P., Strojan, P., Silver, C. E., et al. (2012). Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34, 270–281.CrossRefGoogle ScholarPubMed
Tandon, S., Shahab, S., Benton, J. I., et al. (2008). Fine needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck 30, 1246–1252.CrossRefGoogle Scholar
Vermorken, J. B., Mesia, R., Rivera, F., et al. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 359, 1116–1127.CrossRefGoogle ScholarPubMed
Vermorken, J. B., Stöhlmacher-Williams, J., Davidenko, I., et al. (2013). Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol. 14, 697–710.CrossRefGoogle ScholarPubMed
Weller, M. D., Nankivell, P.C., McConkey, C., et al. (2010). The risk and interval to malignancy of patients with laryngeal dysplasia; A systematic review of case series and meta-analysis. Clin. Otolaryngol. 35, 364–372.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×